Watson Pharmaceuticals

Latest Watson Pharmaceuticals News

1. 
   Parents Blame Alcohol Pads for Toddler's Death

   Mon, 14 Feb 2011

   Industries for its Copaxone product • Novaris Pharmaceuticals for its Extavia (interferon beta 1-b) product • Watson Pharmaceuticals for its Trelstar product • Neuro Resource Group, Inc. for its medical devices and products for injury management
2. Gelnique Approved for Overactive Bladder

   Wed, 28 Jan 2009

   WEDNESDAY, Jan. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Watson Pharmaceuticals ' Gelnique (oxybutynin chloride) to treat symptoms of overactive bladder, the company said in a news release. Gelnique is
3. Health Highlights: Jan. 1, 2009

   Thu, 1 Jan 2009

   on sales visits and other promotions. ----- Firm Says FDA Approves Its Generic Version of Nicotine Gum Watson Pharmaceuticals Inc . said Wednesday that the U.S. Food and Drug Administration had approved its generic version of the nicotine
4. Health Highlights: Dec. 31, 2008

   Wed, 31 Dec 2008

   implementation of smoke-free laws," the study said. ----- Firm Says FDA OKs Its Generic Version of Nicotine Gum Watson Pharmaceuticals Inc . said Wednesday that the U.S. Food and Drug Administration had approved its generic version of the nicotine
5. Rapaflo Approved for Enlarged Prostate

   Thu, 9 Oct 2008

   Rapaflo causes the smooth muscles of the prostate to relax, leading to improved urine flow, the manufacturer, Watson Pharmaceuticals , said in a news release. Common side effects include retrograde ejaculation (a condition in which semen